Pages that link to "Q40668106"
Jump to navigation
Jump to search
The following pages link to Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines (Q40668106):
Displaying 50 items.
- EGFR Signaling in Liver Diseases (Q26771265) (← links)
- Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling (Q28568378) (← links)
- Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. (Q33317737) (← links)
- Genetic and molecular abnormalities in cholangiocarcinogenesis (Q33570262) (← links)
- Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines (Q33611056) (← links)
- Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas (Q33750719) (← links)
- Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation (Q33808159) (← links)
- Regulators of Cholangiocyte Proliferation (Q33863341) (← links)
- Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease (Q33866788) (← links)
- Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy (Q33984809) (← links)
- Cholangiocarcinoma: modern advances in understanding a deadly old disease (Q34000079) (← links)
- Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer (Q34177894) (← links)
- Mechanisms of oxysterol-induced carcinogenesis. (Q34704784) (← links)
- Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts (Q35083913) (← links)
- Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR). (Q35615198) (← links)
- Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes (Q35631762) (← links)
- Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line (Q35751761) (← links)
- Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line (Q36407288) (← links)
- Bile acid interactions with cholangiocytes (Q36506491) (← links)
- The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer (Q36683019) (← links)
- Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment (Q36900063) (← links)
- Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells (Q36988208) (← links)
- AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma (Q37045823) (← links)
- The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts. (Q37095372) (← links)
- c-Met targeted therapy of cholangiocarcinoma (Q37169357) (← links)
- Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression (Q37253350) (← links)
- Bile acids as regulatory molecules (Q37297846) (← links)
- Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma (Q37302761) (← links)
- Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma (Q37351498) (← links)
- Targeted therapy in biliary tract cancer: 2009 update. (Q37650623) (← links)
- Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis (Q37708915) (← links)
- Molecular mechanisms of cholangiocarcinoma (Q37878879) (← links)
- Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis (Q37890253) (← links)
- The bile acid TGR5 membrane receptor: from basic research to clinical application (Q38177434) (← links)
- Formulations of deoxycholic for therapy: a patent review (2011 - 2014). (Q38612255) (← links)
- Chenodeoxycholic acid requires activation of EGFR, EPAC, and Ca2+ to stimulate CFTR-dependent Cl- secretion in human colonic T84 cells (Q38734395) (← links)
- S-Adenosylmethionine suppresses the expression of Smad3/4 in activated human hepatic stellate cells via Rac1 promoter methylation (Q38785542) (← links)
- Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). (Q38812588) (← links)
- Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR/ERK1/2 signaling pathway (Q38894347) (← links)
- The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases. (Q38909010) (← links)
- Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer (Q38993903) (← links)
- Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth (Q39017962) (← links)
- Molecular Markers in the Pathogenesis of Cholangiocarcinoma: Potential for Early Detection and Selection of Appropriate Treatment (Q39033749) (← links)
- Bile acids affect the growth of human cholangiocarcinoma via NF-kB pathway (Q39202139) (← links)
- Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology. (Q39410914) (← links)
- Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells. (Q39493807) (← links)
- A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines (Q40035334) (← links)
- Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2. (Q40241749) (← links)
- Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway (Q40264460) (← links)
- Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats (Q41105428) (← links)